Logo image of NVRI

ENVIRI CORP (NVRI) Stock Fundamental Analysis

NYSE:NVRI - US4158641070 - Common Stock

11.3 USD
+0.23 (+2.08%)
Last: 8/29/2025, 4:15:01 PM
11.3 USD
0 (0%)
After Hours: 8/29/2025, 4:15:01 PM
Fundamental Rating

2

NVRI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. NVRI may be in some trouble as it scores bad on both profitability and health. NVRI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NVRI had negative earnings in the past year.
NVRI had a positive operating cash flow in the past year.
NVRI had negative earnings in each of the past 5 years.
Each year in the past 5 years NVRI had a positive operating cash flow.
NVRI Yearly Net Income VS EBIT VS OCF VS FCFNVRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

NVRI's Return On Assets of -5.68% is on the low side compared to the rest of the industry. NVRI is outperformed by 69.05% of its industry peers.
The Return On Equity of NVRI (-41.84%) is worse than 77.38% of its industry peers.
NVRI has a worse Return On Invested Capital (1.53%) than 60.71% of its industry peers.
NVRI had an Average Return On Invested Capital over the past 3 years of 2.87%. This is significantly below the industry average of 10.78%.
Industry RankSector Rank
ROA -5.68%
ROE -41.84%
ROIC 1.53%
ROA(3y)-4.77%
ROA(5y)-3.06%
ROE(3y)-26.4%
ROE(5y)-16.72%
ROIC(3y)2.87%
ROIC(5y)2.63%
NVRI Yearly ROA, ROE, ROICNVRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

The Operating Margin of NVRI (1.86%) is comparable to the rest of the industry.
NVRI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 18.36%, NVRI is doing worse than 76.19% of the companies in the same industry.
NVRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.86%
PM (TTM) N/A
GM 18.36%
OM growth 3Y-11.02%
OM growth 5Y-12.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1%
GM growth 5Y-3.78%
NVRI Yearly Profit, Operating, Gross MarginsNVRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NVRI is destroying value.
NVRI has more shares outstanding than it did 1 year ago.
NVRI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NVRI is higher compared to a year ago.
NVRI Yearly Shares OutstandingNVRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NVRI Yearly Total Debt VS Total AssetsNVRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

NVRI has an Altman-Z score of 1.81. This is not the best score and indicates that NVRI is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NVRI (1.81) is comparable to the rest of the industry.
NVRI has a Debt/Equity ratio of 3.97. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.97, NVRI is doing worse than 82.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.97
Debt/FCF N/A
Altman-Z 1.81
ROIC/WACC0.17
WACC8.97%
NVRI Yearly LT Debt VS Equity VS FCFNVRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

NVRI has a Current Ratio of 1.19. This is a normal value and indicates that NVRI is financially healthy and should not expect problems in meeting its short term obligations.
NVRI has a Current ratio of 1.19. This is in the lower half of the industry: NVRI underperforms 67.86% of its industry peers.
NVRI has a Quick Ratio of 1.19. This is a bad value and indicates that NVRI is not financially healthy enough and could expect problems in meeting its short term obligations.
NVRI has a worse Quick ratio (0.88) than 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.88
NVRI Yearly Current Assets VS Current LiabilitesNVRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

NVRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1400.00%.
The Revenue has decreased by -0.92% in the past year.
NVRI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.23% yearly.
EPS 1Y (TTM)-1400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y8.22%
Revenue growth 5Y14.23%
Sales Q2Q%-7.83%

3.2 Future

Based on estimates for the next years, NVRI will show a very strong growth in Earnings Per Share. The EPS will grow by 85.86% on average per year.
Based on estimates for the next years, NVRI will show a small growth in Revenue. The Revenue will grow by 2.49% on average per year.
EPS Next Y-608.34%
EPS Next 2Y63.71%
EPS Next 3Y85.86%
EPS Next 5YN/A
Revenue Next Year-4.15%
Revenue Next 2Y-0.29%
Revenue Next 3Y0.92%
Revenue Next 5Y2.49%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NVRI Yearly Revenue VS EstimatesNVRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
NVRI Yearly EPS VS EstimatesNVRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

NVRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 276.96 indicates a quite expensive valuation of NVRI.
NVRI's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of NVRI to the average of the S&P500 Index (22.72), we can say NVRI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 276.96
NVRI Price Earnings VS Forward Price EarningsNVRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200

4.2 Price Multiples

66.67% of the companies in the same industry are more expensive than NVRI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.43
NVRI Per share dataNVRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

NVRI's earnings are expected to grow with 85.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.71%
EPS Next 3Y85.86%

More info and screens

0

5. Dividend

5.1 Amount

NVRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVIRI CORP

NYSE:NVRI (8/29/2025, 4:15:01 PM)

After market: 11.3 0 (0%)

11.3

+0.23 (+2.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners97.36%
Inst Owner ChangeN/A
Ins Owners3.52%
Ins Owner Change16.36%
Market Cap911.35M
Analysts77.78
Price Target15.13 (33.89%)
Short Float %7.53%
Short Ratio8.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-28.8%
Min EPS beat(2)-74.89%
Max EPS beat(2)17.28%
EPS beat(4)2
Avg EPS beat(4)-27.74%
Min EPS beat(4)-115.08%
Max EPS beat(4)61.74%
EPS beat(8)6
Avg EPS beat(8)87.76%
EPS beat(12)10
Avg EPS beat(12)106.02%
EPS beat(16)12
Avg EPS beat(16)93.4%
Revenue beat(2)0
Avg Revenue beat(2)-4.21%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-4.01%
Revenue beat(4)0
Avg Revenue beat(4)-5.54%
Min Revenue beat(4)-8.35%
Max Revenue beat(4)-4.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.38%
Revenue beat(12)6
Avg Revenue beat(12)0.53%
Revenue beat(16)7
Avg Revenue beat(16)-4.27%
PT rev (1m)3.49%
PT rev (3m)3.49%
EPS NQ rev (1m)-147.61%
EPS NQ rev (3m)-141.79%
EPS NY rev (1m)-127.28%
EPS NY rev (3m)-127.28%
Revenue NQ rev (1m)-1.77%
Revenue NQ rev (3m)0.01%
Revenue NY rev (1m)-1.41%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 276.96
P/S 0.41
P/FCF N/A
P/OCF 13.76
P/B 2.42
P/tB N/A
EV/EBITDA 10.43
EPS(TTM)-0.45
EYN/A
EPS(NY)0.04
Fwd EY0.36%
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)0.82
OCFY7.27%
SpS27.81
BVpS4.67
TBVpS-8.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.68%
ROE -41.84%
ROCE 1.95%
ROIC 1.53%
ROICexc 1.61%
ROICexgc 3.27%
OM 1.86%
PM (TTM) N/A
GM 18.36%
FCFM N/A
ROA(3y)-4.77%
ROA(5y)-3.06%
ROE(3y)-26.4%
ROE(5y)-16.72%
ROIC(3y)2.87%
ROIC(5y)2.63%
ROICexc(3y)3.01%
ROICexc(5y)2.75%
ROICexgc(3y)6.33%
ROICexgc(5y)5.89%
ROCE(3y)3.66%
ROCE(5y)3.35%
ROICexcg growth 3Y0.32%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y1.95%
ROICexc growth 5Y-1.33%
OM growth 3Y-11.02%
OM growth 5Y-12.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1%
GM growth 5Y-3.78%
F-Score2
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 3.97
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 76.88%
Cap/Sales 6.14%
Interest Coverage 250
Cash Conversion 30.01%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.88
Altman-Z 1.81
F-Score2
WACC8.97%
ROIC/WACC0.17
Cap/Depr(3y)80.65%
Cap/Depr(5y)82.53%
Cap/Sales(3y)6.35%
Cap/Sales(5y)7.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
EPS Next Y-608.34%
EPS Next 2Y63.71%
EPS Next 3Y85.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y8.22%
Revenue growth 5Y14.23%
Sales Q2Q%-7.83%
Revenue Next Year-4.15%
Revenue Next 2Y-0.29%
Revenue Next 3Y0.92%
Revenue Next 5Y2.49%
EBIT growth 1Y-69.21%
EBIT growth 3Y-3.7%
EBIT growth 5Y0.27%
EBIT Next Year139.77%
EBIT Next 3Y40.64%
EBIT Next 5Y25.03%
FCF growth 1Y12.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.61%
OCF growth 3Y2.64%
OCF growth 5YN/A